Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
73,730.64
(
1.03%
)
News Focus
News Focus
Post# of 405172
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

attilathehunt

Send PM Follow Ignore
Followers 70
Posts 8968
Boards Moderated 0
Alias Born 03/06/2016

attilathehunt

Re: Phoenix300 post# 382988

Tuesday, 11/09/2021 6:07:43 PM

Tuesday, November 09, 2021 6:07:43 PM

Post# of 405172
?On November 4, 2021, the Company issued 2,036 shares of its Series B-2 5% convertible preferred stock, for aggregate gross proceeds of approximately $2 million, upon exercise of 2,036 Series 2 warrants issued by the Company. ?


So the next day we took the haircut.

"We hold FTD, RPDD, and ODD for Rett." Coupled with clinically meaningful & statistically significant data will move the FDA to AA...What's the point in issuing these designations if clinically meaningful and stat sig data isn't enough? Approval in 3 mo

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote